Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Status:
Completed
Trial end date:
2016-10-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prospectively assess the long-term outcomes (benefits and
risks) associated with entecavir (ETV) therapy as compared to other antivirals approved for
the treatment of chronic HBV infection. For the China substudy, patients randomized to
entecavir will have safety and efficacy assessments performed during the first year of the
study.